Nse: Kopran, Kopran Ltd. Is a maintaining corporation, which engages within the production of pharmaceuticals and associated products. It operates thru the subsequent business units: Formulations, and Active Pharmaceutical Ingredients. The company’s merchandise consist of Amyn, Lokit, and Ciproquin. The corporation became based on April 26, 1958 and is situated in Mumbai, India.
Table of Contents
About NSE: KOPRAN LTD
ISIN Sector
INE082A01010 Health Technology
Industry Website
Pharmaceuticals: Major kopran.com
Headquarters Employees
Mumbai 678
Founded
1958
Nse: Kopran Ltd
Financials
(INR)2022info
FISCAL YEAR ENDED 3/31/2022.
Y/Y CHANGE
Revenue/Income
Total sum of income generated by the sale of goods or services related to the company’s primary operations
4.78B-2.91%
Operating cost
Represents the total experienced expenses through normal operations
1.26B9.87%
Net revenue
Corporation’s earnings for a period net of operating costs, taxes, and interest
610.31M-0.93%
Net income turnover profit
Measures how much net amount or profit is generated as a percentage of revenue.
12.782.00%
Earnings income pershare
Represents the corporation’s profit separated by the out’standing shares of its common stock.
——
EBITDA
Incomes before interest, taxes, depreciation, and amortization, is a measure of a organisation’s general economic overall performance and is used as an alternative to net profits in a few circumstances
872.95M6.45%
Effective tax rates
The percent of their income that a company pays in taxes
25.37%—
Balance Sheet
Total assets
Total liabilities
| (INR) | 2022info
FISCAL YEAR ENDED 3/31/2022. |
Y/Y CHANGE |
| Cash and short-term investment
Investment’s that are relatively liquid and have maturities between 3 months and one year |
58.68M | 527.42% |
| Total asset
The full amount of assets owned by a company |
6.11B | 39.03% |
| Total charges
Sum of the joint debts a company owes |
1.85B | -4.96% |
| Total evenhandedness
The worth of subtracting the total liabilities from the total assets of a company |
4.26B | — |
| Shares outstanding’s
Total number’s of common shares outstanding as of the latest date disclosed in a financial filing |
48.21M | — |
| Price to volume
A ratio use to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock |
1.64 | — |
| Return on asset’s
A financial ratio that shows a companys profitability compared to its assets |
9.15% | — |
| Returns on capetal
Company’s returns above the average cost it pays for its debt and equity capital |
11.84% | — |
Cash Flow
Net change in cash
| (INR) | 2022info
FISCAL YEAR ENDED 3/31/2022. |
Y/Y CHANGE |
| Net revenue
Corporation’s earnings for a period net of operating costs, taxes, and interest |
610.31M | -0.93% |
| Money from processes
Net cash use or generated for core business activities |
-334.75M | -155.84% |
| Cash from investments
Net cash use or generated in investing activities such as purchasing assets |
-844.15M | -233.93% |
| Cash from funding
Net cash use or generated in financing activities such as dividend payments and loans |
1.23B | 455.28% |
| Net changes in money
The amount by which a corporation’s cash balance increases or decreases in an accounting period |
49.33M | 4,793.85% |
| Free cash movement
Volume of cash a business has after it has met its financial obligations such as debt and outstanding payments |
-1.38B | -2,819.06% |
Stocks
Ownership of a fragment of a organization and the right to assert a percentage of the organization’s belongings and income equal to the amount of stock owned
IN listed security
Listed on NSE
IN headquartered
Headquartered in India
PREVIOUS CLOSE
The last closing price
₹144.95
DAY amount
The amount between the high and low prices over the past day
₹144.00 – ₹149.00
YEAR Amount
The amount between the high and low prices over the past 52 weeks
₹96.00 – ₹287.35
MARKET-CAP
A estimation method that multiplies the price of a company’s stock by the total number of outstanding shares.
7.12B INR
P/E SHARE
The ratio of present share price to trailing 12 month EPS that signals if the price is high or low compared to other stocks
19.23
BONUS YIELD
The ratio of annual bonus to current share price that estimates the dividend return of a stock
2.03%
PRIMARY EXCHANGE
Listed exchange for this security
NSE
Price info of Nse: Kopran Ltd
Margin & Trade Information of Nse: Kopran Ltd
- Traded Volume
69,724 (Shares)
- Traded Value
₹ 10,308,693.83
| VAR Margin | | | ELM Margin | | | Adhoc | | | Total Margin |
| 21.85 | + | 3.50 | + | 24.65 | = | 50 |
Quick Overview of Kopran Ltd
| Market Cap (Cr): 891 | Face Value (₹): 10 | EPS (₹): 13.8 |
| Book Value (₹): 88.4 | Roce (%): 21.4 | Debt to Equity: 0.20 |
| Stock P/E: 14.3 | ROE (%): 18.2 | Dividend Yield (%): 1.62 |
| Revenue (Cr): 475 | Earnings (Cr): 80 | Cash (Cr): 57 |
| Total Debt (Cr): 75 | Promoter’s Holdings (%): 43.78 |
Valuation Analysis of Kopran Ltd
Today’s Market Action
The last traded share price of Nse: Kopran Ltd was 149.25 up by 2.97% on the NSE. It’s last traded stock price on BSE was 149.35 up by 2.82%. The total size of shares on NSE and BSE mutual was 79,010 shares. Its total combined turnover was Rs 1.17 crores.
Medium and Long Term Market Action
Kopran Ltd hit a 52-week high of 287.35 on 29-04-2022 and a 52-week low of 96 on 28-03-2023. The stock price of Nse: Kopran Ltd is up by 43% over the last one month. It is down by -47.4% over the last one year.
Related Searches
kopran share price target
kopran pharma share price
Nse: kopran Results
kopran share price target 2023
kopran news today
Nse: kopran share price target 2025
kopran pharma product list
kopran share price target tomorrow
